04-Nov-2026 19:55:20

AUROBINDO PHARMA Q2 FY27 ; NET PROFIT UP 33% AT ₹1,124 CR (YOY), UP 9% (QOQ)

REVENUE UP 24% AT ₹10,263 CR (YOY), UP 12% (QOQ) EBITDA UP 28% AT ₹2,156 CR (YOY), UP 15% (QOQ) MARGINS AT 21.0% VS 20.3% (YOY), 20.6% (QOQ)

AUROBINDO PHARMA LTD